L-Type Amino Acid Transporter 1 (LAT1) Expression in Canine Mammary Gland Tumors

被引:9
作者
Fukumoto, Shinya [1 ]
Hanazono, Kiwamu [1 ]
Komatsu, Takahiro [1 ]
Iwano, Hidetomo [2 ]
Kadosawa, Tsuyoshi [1 ]
Uchide, Tsuyoshi [1 ]
机构
[1] Rakuno Gakuen Univ, Sch Vet Med, Dept Small Anim Clin Sci, Ebetsu, Hokkaido 0698501, Japan
[2] Rakuno Gakuen Univ, Sch Vet Med, Dept Basic Vet Med, Ebetsu, Hokkaido 0698501, Japan
基金
日本学术振兴会;
关键词
canine; LAT1; expression; mammary gland tumor; BREAST-CANCER CELLS; SYSTEM-L; HEAVY-CHAIN; IDENTIFICATION; PROGNOSIS; GROWTH; LUNG; CD98;
D O I
10.1292/jvms.12-0356
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
L-type amino acid transporter 1 (LAT1), an isoform of amino acid transport system L, transports branched or aromatic amino acids essential for fundamental cellular activities such as cellular growth, proliferation and maintenance. This amino acid transporter recently has received attention because of its preferential and up-regulated expression in a variety of human tumors, in contrast to its limited distribution and low-level expression in normal tissues. In this study, to explore the feasibility of using LAT1 expression as a molecular marker in mammary gland tumors (MGT), we performed a comparative study of LAT1 expression at the mRNA and protein levels in normal mammary gland cells and tumor cells. Conventional RT-PCR and Western blotting were performed on MGT tissues from 16 dogs and normal organs from nine healthy dogs. LAT1 expression was detected in ten of the 16 MGT patients. As is the case in human tissues, LAT1 showed limited expressional distribution in normal canine organs. For quantitative expressional comparison, extensive real-time RT-PCR was performed on mRNA samples from 53 MGT patients. The comparison demonstrated that LAT1 mRNA levels from MGT tissues were 20 times higher than those in normal mammary gland tissues. Additionally, histologically invasive MGT showed a higher expression of LAT1 than non-invasive tumors. These findings suggest that LAT1 could be a clinical marker and therapeutic target for invasive malignant MGT.
引用
收藏
页码:431 / 437
页数:7
相关论文
共 26 条
[1]   Identification of a novel system L amino acid transporter structurally distinct from heterodimeric amino acid transporters [J].
Babu, E ;
Kanai, Y ;
Chairoungdua, A ;
Kim, DK ;
Iribe, Y ;
Tangtrongsup, S ;
Jutabha, P ;
Li, YW ;
Ahmed, N ;
Sakamoto, S ;
Anzai, N ;
Nagamori, S ;
Endou, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (44) :43838-43845
[2]   DETECTION OF THE GLUT3 FACILITATIVE GLUCOSE TRANSPORTER IN RAT L6 MUSCLE-CELLS - REGULATION BY CELLULAR-DIFFERENTIATION, INSULIN AND INSULIN-LIKE GROWTH FACTOR-I [J].
BILAN, PJ ;
MITSUMOTO, Y ;
MAHER, F ;
SIMPSON, IA ;
KLIP, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 186 (02) :1129-1137
[3]   Identification of LAT4, a novel amino acid transporter with system L activity [J].
Bodoy, S ;
Martín, L ;
Zorzano, A ;
Palacín, M ;
Estévez, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (12) :12002-12011
[4]   ROLE OF AMINO-ACID-TRANSPORT AND COUNTERTRANSPORT IN NUTRITION AND METABOLISM [J].
CHRISTENSEN, HN .
PHYSIOLOGICAL REVIEWS, 1990, 70 (01) :43-77
[5]   Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2 [J].
del Amo, Eva M. ;
Urtti, Atto ;
Yliperttula, Marjo .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 35 (03) :161-174
[6]   Correlation of L-type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosis [J].
Furuya, Mio ;
Horiguchi, Jun ;
Nakajima, Hiroki ;
Kanai, Yoshikatsu ;
Oyama, Tetsunari .
CANCER SCIENCE, 2012, 103 (02) :382-389
[7]   Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I-III nonsmall cell lung cancer [J].
Kaira, K. ;
Oriuchi, N. ;
Imai, H. ;
Shimizu, K. ;
Yanagitani, N. ;
Sunaga, N. ;
Hisada, T. ;
Tanaka, S. ;
Ishizuka, T. ;
Kanai, Y. ;
Endou, H. ;
Nakajima, T. ;
Mori, M. .
BRITISH JOURNAL OF CANCER, 2008, 98 (04) :742-748
[8]   Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98) [J].
Kanai, Y ;
Segawa, H ;
Miyamoto, K ;
Uchino, H ;
Takeda, E ;
Endou, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (37) :23629-23632
[9]   Heterodimeric amino acid transporters: Molecular biology and pathological and pharmacological relevance [J].
Kanai, Y ;
Endou, H .
CURRENT DRUG METABOLISM, 2001, 2 (04) :339-354
[10]   Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells [J].
Kim, D ;
Kanai, Y ;
Choi, HW ;
Tangtrongsup, S ;
Chairoungdua, A ;
Babu, E ;
Tachampa, K ;
Anzai, N ;
Iribe, Y ;
Endou, H .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2002, 1565 (01) :112-122